099: Rh Immune Globulin (Teaching Episode)
Rh Immune Globulin prevents at-risk moms from making anti-D, but calculating proper dose can be challenging. Let's simplify things!
Rh Immune Globulin prevents at-risk moms from making anti-D, but calculating proper dose can be challenging. Let's simplify things!
CE episode! When red cell alloantibodies are unpredictable, the monocyte monolayer assay can clear things right up! Sandy Nance explains this very useful test.
CE episode! RHD genotyping has not been as widely implemented as we had hoped. Sue Johnson is here to tell us why and how we can do better!
Warm autoantibodies have a well-deserved reputation as tough challenges. Two experts show you some best practices to make things easier.
Uh-oh! Your patient needs blood, but EVERYTHING is incompatible! Jill Storry says, "Take it easy. Here's what to do next." NOTE: CE credit has expired for this episode.
Despite "matching," harmful RBC antibodies in patients with sickle cell disease still happen. Are we doing enough? Dr. Stella Chou details our next steps. NOTE: CE credit has expired for this episode.
Anti-CD47 is an exciting new cancer drug that totally messes up routine blood bank testing! Connie Westhoff shows how to get past the interference and keep patients safe. NOTE: CE credit has expired for this episode.
Do females that could have babies in the future need to be matched for antigens like K to prevent HDFN? Meghan Delaney explains what she discovered in the "AMIGO Study."
Isolated nonspecific reactions ("antibodies of undetermined specificity") on antibody workups are common and irritating, but are they important? Brenda Grossman explains.
By popular demand, it's time for ABO Discrepancies! Nicole Draper gives you three rules that will help you solve most of these cases.
Alloimmunization has been a mystery for decades, but Chris Tormey has new answers for why patients make antibodies we wish they didn't! NOTE: CE credit has expired for this episode.
Sue Johnson shows us how to choose compatible blood products and TEST them to make sure they are compatible (2 of 2).
Sue Johnson returns to explain specimen requirements and patient serologic testing (part 1 of 2). NOTE: CE credit has expired for this episode.
Hemolytic Disease of the Fetus and Newborn (HDFN) seems simple, but there are lots of pitfalls! Greg Denomme guides us to HDFN clarity!
Molecular testing is everywhere in medicine today, and the blood bank is no exception! Meghan Delaney shows us how it all fits.
For what is really a simple test, the Direct Antiglobulin Test (DAT) can be surprisingly confusing and complex. Sue Johnson is here to guide us to clarity!
Drug-induced immune hemolytic anemia seems complicated (and it can be!). Pat Arndt dispenses some clear guidance to treat your confusion!
Daratumumab…Funny name, promising drug! Dr. Rick Kaufman is an authority on DARA’s confusing effects on BB testing, and he’s here to help.
Dr. Chaffin opens the BBGuy mailbag to discuss D variants, Liquid Plasma, warm autoantibody issues, and directed donor blood collections.
You should be using RHD genotyping, says Dr. Connie Westhoff, in particular in patients with unexpected results on serologic D typing. Learn why here.